The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Major Depressive Disorder (MDD) is one of the most burdensome illnesses globally, with significant negative impacts on activities of daily living, quality of life, cognitive function, and employment status and work productivity [1,2].Researchers studying MDD are challenged by the complex nature of the disease, which is often comorbid with other chronic and acute conditions, including both physical and psychiatric disorders.In particular, the treatment pathway for patients with MDD is remarkably complicated, with extensive variability in disease presentation, uncertainty of diagnoses, and heterogeneity of treatment effects.The research featured in this special issue of Pharma-coEconomics draws on findings from a variety of countries across North America, Europe, Asia, and Oceania.Although differences in culture as well as health and social care systems complicate research in MDD, a broad survey of studies of the burden of MDD provides an opportunity for new insights concerning the many determinants of health outcomes associated with this disease.This editorial overview surveys these studies, focusing on several unifying themes:1. Growing prevalence of MDD, particularly during the coronavirus disease 2019 (COVID-19) pandemic 2. Research concerning the cost of MDD 3. Economic burden of MDD in subpopulations 4. Advances in analytical methods 5. Implications for researchers and policy makers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Self-citationHealth, T. L. G. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30432-0 · Cited by 417
Cited by
Does insomnia treatment prevent depression?
Boland, E. M., Goldschmied, J. R., & Gehrman, P. R. (2023) · SLEEP · doi:10.1093/sleep/zsad104 · Cited by 69
Chehadi, A. C., Pereira de Lima, E., Detregiachi, C. R. P., Santos de Argollo Haber, R., Catharin, V. M. C. S., Fornari Laurindo, L., Engracia Valenti, V., Machado Galhardi, C., Tanaka, M., & Maria Barbalho, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010465 · Cited by 8
Metadata
- Authors
- Proudman, D., Greenberg, P., & Nellesen, D.
- Venue
- PharmacoEconomics
- Published
- 2021-05-20
- Volume
- 39
- Issue
- 6
- Pages
- 619-625
- ISSN
- 1170-7690 (ISSN-L)
- 1179-2027
- OpenAlex
- W3163489461
- Cited by
- 194
- References
- 3
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. https://app.cochat.ai/papers/10.1007/s40273-021-01040-7
- The paper
- Proudman, D., Greenberg, P., & Nellesen, D. (2021). The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. PharmacoEconomics. https://doi.org/10.1007/s40273-021-01040-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.